SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Edelman Joseph, et al. – ‘4’ for 11/16/05 re: Endo Pharmaceuticals Solutions Inc.

On:  Monday, 11/21/05, at 5:03pm ET   ·   For:  11/16/05   ·   As:  10% Owner   ·   Accession #:  1193805-5-2318   ·   File #:  0-18728

Previous ‘4’:  ‘4’ on 12/6/04 for 12/2/04   ·   Next:  ‘4’ on 11/23/05 for 11/21/05   ·   Latest:  ‘4’ on 4/15/24 for 4/11/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/05  Edelman Joseph                    4          10% Owner   2:10K  Indevus Pharmaceuticals Inc.      E-Data Systems, Inc./FA
          Perceptive Advisors LLC
          Perceptive Life Sciences Master Fund Ltd.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      9K 
                Securities by an Insider -- e501205_ex.xml/2.2                   
 2: EX-99.1     Information Regarding Joint Filers                     1      5K 


‘4’   —   Statement of Changes in Beneficial Ownership of Securities by an Insider — e501205_ex.xml/2.2




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0202
Document Type:  4
Period of Report:  11/16/05
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  854222
Issuer Name:  INDEVUS PHARMACEUTICALS INC
Issuer Trading Symbol:  IDEV
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1164426
Owner Name:  EDELMAN JOSEPH
Reporting Owner Address:
Owner Street 1:  C/O FIRST NEW YORK SECURITIES
Owner Street 2:  850 THIRD AVENUE, 8TH FLOOR
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10022
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1249675
Owner Name:  PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Reporting Owner Address:
Owner Street 1:  5437 CONNECTICUT AVE NW STE 100
Owner Street 2:
Owner City:  WASHINGTON
Owner State:  DC
Owner ZIP Code:  20015
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1224962
Owner Name:  PERCEPTIVE ADVISORS LLC
Reporting Owner Address:
Owner Street 1:  PERCEPTIVE CAPITAL
Owner Street 2:  5437 CONNECTICUT AVENUE NW STE 100
Owner City:  WASHINGTON
Owner State:  DC
Owner ZIP Code:  20015
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Footnote ID:  F1
Transaction Date:
Value:  11/16/05
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  18,000
Footnote ID:  F2
Transaction Price Per Share:
Value:  4.08
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  1,051,830
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F2
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Footnote ID:  F1
Transaction Date:
Value:  11/16/05
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  2000
Footnote ID:  F3
Transaction Price Per Share:
Value:  4.08
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  106,900
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F3
Footnotes:
Footnote - F1This Form 4 is being filed by Joseph Edelman, Perceptive Life Science Master Fund Ltd. ("Master Fund") and Perceptive Advisors LLC ("Advisors").
Footnote - F2This transaction was effected through Master Fund. Mr. Edelman is the managing member of Advisors, which in turn serves as the investment manager of Master Fund. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. Each of Mr. Edelman and Advisors disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or Advisors is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote - F3This transaction was effected through an account of First New York Trading, LLC, over which Mr. Edelman has sole voting and dispositive power. Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Owner Signature:
Signature Name:  /s/ Andrew Sankin, as attorney in fact
Signature Date:  11/21/05


Top
Filing Submission 0001193805-05-002318   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 12:38:28.2am ET